These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18192035)

  • 41. Diagnostic and prognostic significance of plasma N-terminal-pro-brain natriuretic peptide in decompensated heart failure with preserved ejection fraction.
    Paul B; Soon KH; Dunne J; De Pasquale CG
    Heart Lung Circ; 2008 Dec; 17(6):497-501. PubMed ID: 18722158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High plasma adiponectin is related to low functional capacity in patients with chronic heart failure.
    Laoutaris ID; Vasiliadis IK; Dritsas A; Mavrogeni S; Kallistratos MS; Manginas A; Chaidaroglou A; Degiannis D; Panagiotakos DB; Cokkinos DV
    Int J Cardiol; 2010 Oct; 144(2):230-1. PubMed ID: 19176260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C-type natriuretic peptide in individuals with normal left ventricular systolic function.
    Kuo JY; Yeh HI; Chang SH; Shih BF; Wang AM; Chen CY; Hou CJ
    Scand Cardiovasc J; 2007 Jun; 41(3):155-9. PubMed ID: 17487764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adiponectin, diabetes and ischemic heart failure: a challenging relationship.
    Baldasseroni S; Antenore A; Di Serio C; Orso F; Lonetto G; Bartoli N; Foschini A; Marella A; Pratesi A; Scarantino S; Fumagalli S; Monami M; Mannucci E; Marchionni N; Tarantini F
    Cardiovasc Diabetol; 2012 Dec; 11():151. PubMed ID: 23249664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact in
    Agra RM; Fernández-Trasancos Á; Díaz-Rodríguez E; Cordero A; Varela-Román A; Gómez-Otero I; Canoa JNL; Fernández ÁL; Martínez-Cereijo JM; González-Juanatey JR; Eiras S
    Int J Med Sci; 2018; 15(5):417-424. PubMed ID: 29559829
    [No Abstract]   [Full Text] [Related]  

  • 46. Plasma adiponectin concentration and its association with metabolic syndrome in patients with heart failure.
    Won H; Kang SM; Shin MJ; Oh J; Hong N; Park S; Lee SH; Jang Y; Chung N
    Yonsei Med J; 2012 Jan; 53(1):91-8. PubMed ID: 22187237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation Between Mitochondrial DNA Content Measured in Myocardium and Peripheral Blood of Patients with Non-Ischemic Heart Failure.
    Knez J; Lakota K; Božič N; Okrajšek R; Cauwenberghs N; Thijs L; Kneževič I; Vrtovec B; Tomšič M; Čučnik S; Sodin-Šemrl S; Kuznetsova T; Brguljan-Hitij J
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):736-741. PubMed ID: 29087733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The evolving role of adiponectin as an additive biomarker in HFrEF.
    Sente T; Gevaert A; Van Berendoncks A; Vrints CJ; Hoymans VY
    Heart Fail Rev; 2016 Nov; 21(6):753-769. PubMed ID: 27480276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does adiponectin resistance exist in chronic heart failure?
    Kintscher U
    Eur Heart J; 2007 Jul; 28(14):1676-7. PubMed ID: 17591684
    [No Abstract]   [Full Text] [Related]  

  • 50. Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure.
    Loncar G; Fülster S; von Haehling S; Popovic V
    Int J Cardiol; 2013 Jan; 162(2):77-85. PubMed ID: 21982619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and Humoral Determinants of Congestion in Heart Failure: Potential Role of Adiponectin.
    Monzo L; Kotrc M; Benes J; Sedlacek K; Jurcova I; Franekova J; Jarolim P; Kautzner J; Melenovsky V
    Kidney Blood Press Res; 2019; 44(5):1271-1284. PubMed ID: 31553971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.
    Van Berendoncks AM; Garnier A; Ventura-Clapier R; Conraads VM
    Heart Fail Rev; 2013 Sep; 18(5):557-66. PubMed ID: 23090715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum adiponectin in non-cachectic heart failure patients.
    Daniels KM; Zavin A; Allsup K; Joseph J; Arena R; Lazzari AA; Schulze PC; Lecker SH; Brown J; Forman DE
    Int J Cardiol; 2013 Oct; 168(4):4363-4. PubMed ID: 23739548
    [No Abstract]   [Full Text] [Related]  

  • 54. Adiponectin: sometimes good, sometimes bad?
    Ebert T; Fasshauer M
    Cardiology; 2011; 118(4):236-7. PubMed ID: 21720158
    [No Abstract]   [Full Text] [Related]  

  • 55. Adiponectin and risk of congestive heart failure.
    Ingelsson E; Risérus U; Berne C; Frystyk J; Flyvbjerg A; Axelsson T; Lundmark P; Zethelius B
    JAMA; 2006 Apr; 295(15):1772-4. PubMed ID: 16622137
    [No Abstract]   [Full Text] [Related]  

  • 56. Adiponectin: Just Along for the Ride?
    Turer AT; Scherer PE
    Circ Res; 2016 Jul; 119(3):407-8. PubMed ID: 27458194
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum adiponectin after ischemic stroke.
    Takeuchi S; Otani N; Nawashiro H
    Acta Neurol Scand; 2011 Aug; 124(2):149; author reply 150. PubMed ID: 21732921
    [No Abstract]   [Full Text] [Related]  

  • 58. Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure.
    Doshi D; Ben-Yehuda O; Bonafede M; Josephy N; Karmpaliotis D; Parikh MA; Moses JW; Stone GW; Leon MB; Schwartz A; Kirtane AJ
    J Am Coll Cardiol; 2017 Jan; 69(3):364-365. PubMed ID: 28104081
    [No Abstract]   [Full Text] [Related]  

  • 59. Adiponectin is valuable in the diagnosis of acute heart failure with renal insufficiency.
    Dai Z; Zhang Y; Ye H; Zhang G; Jin H; Chen Z; Yao Y; Tian X; Zhou J; Li P; Liang X; Xie H; Ge S; Zhang Z
    Exp Ther Med; 2018 Sep; 16(3):2725-2734. PubMed ID: 30210613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges.
    Lei X; Qiu S; Yang G; Wu Q
    Genes Dis; 2023 Jul; 10(4):1525-1536. PubMed ID: 37397515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.